ICD-10: M02.359

Reiter's disease, also known as reactive arthritis, is a type of inflammatory arthritis that typically occurs in response to an infection in another part of the body. The ICD-10 code M02.359 specifically refers to Reiter's disease affecting the unspecified hip. Below is a detailed clinical description and relevant information regarding this condition.

Clinical Description of Reiter's Disease

Definition and Etiology

Reiter's disease is characterized by a triad of symptoms: arthritis, urethritis, and conjunctivitis. It is often triggered by infections, particularly those caused by certain bacteria such as Chlamydia trachomatis, Salmonella, Shigella, or Yersinia. The condition is more common in young adults and is associated with the HLA-B27 antigen, which is present in a significant number of affected individuals.

Symptoms

The symptoms of Reiter's disease can vary but typically include:
- Arthritis: Joint pain and swelling, which can affect one or multiple joints. In the case of M02.359, the hip joint is specifically involved, leading to pain and reduced mobility in that area.
- Urethritis: Inflammation of the urethra, which may cause painful urination and discharge.
- Conjunctivitis: Inflammation of the eye, leading to redness, irritation, and discharge.

Diagnosis

Diagnosis of Reiter's disease is primarily clinical, based on the presence of the characteristic symptoms and a history of preceding infections. Laboratory tests may include:
- Blood tests: To check for markers of inflammation (e.g., ESR, CRP) and the presence of the HLA-B27 antigen.
- Joint fluid analysis: To rule out other types of arthritis, such as gout or septic arthritis.

Treatment

Management of Reiter's disease focuses on alleviating symptoms and addressing the underlying infection if present. Treatment options may include:
- Nonsteroidal anti-inflammatory drugs (NSAIDs): To reduce pain and inflammation.
- Corticosteroids: In cases of severe inflammation.
- Antibiotics: If a bacterial infection is identified as the trigger.

ICD-10 Code M02.359: Specifics

The ICD-10 code M02.359 is categorized under "Reactive arthritis" and is used when the specific joint affected is the hip, but the details of the condition are unspecified. This code is part of a broader classification that helps healthcare providers document and bill for the condition accurately.

Importance of Accurate Coding

Accurate coding is crucial for:
- Clinical documentation: Ensuring that the patient's medical records reflect their condition accurately.
- Insurance billing: Facilitating appropriate reimbursement for healthcare services provided.
- Epidemiological tracking: Assisting in the understanding of the prevalence and impact of Reiter's disease in the population.

Conclusion

Reiter's disease, particularly when affecting the hip as indicated by ICD-10 code M02.359, is a significant condition that requires careful diagnosis and management. Understanding its clinical presentation, potential triggers, and treatment options is essential for effective patient care. Accurate coding not only aids in treatment but also contributes to broader healthcare data collection and analysis. If you have further questions or need additional information, feel free to ask!

Reiter's disease, also known as reactive arthritis, is a type of inflammatory arthritis that typically occurs following an infection, particularly in the urogenital or gastrointestinal tract. The ICD-10 code M02.359 specifically refers to Reiter's disease affecting the unspecified hip. Below is a detailed overview of the clinical presentation, signs, symptoms, and patient characteristics associated with this condition.

Clinical Presentation

Reiter's disease is characterized by a triad of symptoms: arthritis, urethritis, and conjunctivitis. However, not all patients will present with all three symptoms. The condition often develops after a triggering infection, which can lead to the following clinical features:

Signs and Symptoms

1. Arthritis:
   - Joint Pain and Swelling: Patients typically experience pain and swelling in the affected joints, which may include the hip, knees, and ankles. In the case of M02.359, the hip is specifically involved.
   - Asymmetrical Involvement: The arthritis is often asymmetrical, meaning it may affect one hip more than the other or involve different joints on either side of the body.
   - Morning Stiffness: Patients may report stiffness in the affected joints, particularly after periods of inactivity, such as in the morning.

2. Urethritis:
   - Dysuria: Patients may experience painful urination, which can be a result of the underlying infection that triggered the arthritis.
   - Increased Urinary Frequency: There may be a frequent urge to urinate, often accompanied by discomfort.

3. Conjunctivitis:
   - Eye Symptoms: Some patients may develop conjunctivitis, leading to redness, irritation, and discharge from the eyes.

4. Skin Manifestations:
   - Psoriasis-like Lesions: Some individuals may develop skin lesions that resemble psoriasis, particularly on the palms and soles.

5. Systemic Symptoms:
   - Fatigue and Malaise: General feelings of tiredness and unwellness are common.
   - Fever: Low-grade fever may occur, especially during the acute phase of the disease.

Patient Characteristics

• Demographics: Reiter's disease is more common in young adults, particularly males aged 20 to 40 years. However, it can affect individuals of any age and gender.
• History of Infection: A significant number of patients report a history of a recent infection, particularly sexually transmitted infections (like Chlamydia) or gastrointestinal infections (such as those caused by Salmonella or Shigella).
• Family History: There may be a genetic predisposition, as the condition is associated with the HLA-B27 antigen, which is found more frequently in individuals with this antigen.

Conclusion

Reiter's disease, classified under ICD-10 code M02.359, presents with a range of symptoms primarily affecting the hip joint, along with potential systemic manifestations. Understanding the clinical presentation and patient characteristics is crucial for timely diagnosis and management. If you suspect Reiter's disease, it is essential to conduct a thorough clinical evaluation, including a review of recent infections and a physical examination of the affected joints. Early intervention can help manage symptoms and improve the quality of life for affected individuals.

Reiter's disease, also known as reactive arthritis, is a type of inflammatory arthritis that can occur following an infection. The ICD-10 code M02.359 specifically refers to Reiter's disease that is unspecified and affects the hip. Here are some alternative names and related terms associated with this condition:

Alternative Names

1. Reactive Arthritis: This is the most common alternative name for Reiter's disease, emphasizing its association with preceding infections.
2. Postinfectious Arthritis: This term highlights the condition's development following an infection, which is a key characteristic of Reiter's disease.
3. Reiter's Syndrome: This term is often used interchangeably with Reiter's disease, although it can sometimes refer to a broader set of symptoms, including urethritis and conjunctivitis.

Related Terms

1. Spondyloarthritis: Reiter's disease is classified under the umbrella of spondyloarthritis, a group of inflammatory rheumatic diseases that affect the spine and joints.
2. Enthesitis: This term refers to inflammation at the sites where tendons or ligaments insert into the bone, which can be a feature of Reiter's disease.
3. Urethritis: Often associated with Reiter's disease, this term refers to inflammation of the urethra, which can occur alongside the arthritis.
4. Conjunctivitis: This is another common symptom associated with Reiter's disease, referring to inflammation of the eye's conjunctiva.
5. HLA-B27 Positive: Many patients with Reiter's disease test positive for the HLA-B27 antigen, which is associated with various autoimmune conditions.

Conclusion

Understanding the alternative names and related terms for ICD-10 code M02.359 can help in recognizing the broader context of Reiter's disease and its implications in clinical practice. This knowledge is essential for accurate diagnosis, treatment planning, and effective communication among healthcare providers. If you need further information or specific details about treatment options or management strategies for Reiter's disease, feel free to ask!

Reiter's disease, also known as reactive arthritis, is a type of inflammatory arthritis that can occur following an infection, particularly in the urogenital or gastrointestinal tract. The ICD-10 code M02.359 specifically refers to Reiter's disease affecting the unspecified hip. To diagnose this condition, healthcare providers typically follow a set of clinical criteria and guidelines.

Diagnostic Criteria for Reiter's Disease

1. Clinical History

• Recent Infection: A history of a recent infection, particularly in the urogenital or gastrointestinal systems, is crucial. Common pathogens include Chlamydia trachomatis, Salmonella, Shigella, and Campylobacter.
• Symptoms: Patients often present with a triad of symptoms: arthritis, urethritis, and conjunctivitis. However, not all symptoms need to be present for a diagnosis.

2. Physical Examination

• Joint Involvement: The examination may reveal swelling, tenderness, and limited range of motion in the affected hip joint. Other joints may also be involved, but the hip is specifically noted in this case.
• Extra-Articular Manifestations: Signs of conjunctivitis or urethritis may also be assessed during the physical examination.

3. Laboratory Tests

• Serological Tests: Testing for the presence of HLA-B27 antigen can support the diagnosis, as a significant percentage of patients with Reiter's disease are HLA-B27 positive.
• Infection Screening: Cultures or serological tests may be performed to identify any underlying infections that could have triggered the reactive arthritis.

4. Imaging Studies

• X-rays or MRI: Imaging may be utilized to assess joint damage or inflammation in the hip. X-rays can show changes associated with arthritis, while MRI can provide more detailed images of soft tissue and bone.

5. Exclusion of Other Conditions

• Differential Diagnosis: It is essential to rule out other forms of arthritis, such as rheumatoid arthritis, psoriatic arthritis, or septic arthritis, which may present with similar symptoms.

Conclusion

The diagnosis of Reiter's disease (ICD-10 code M02.359) involves a comprehensive approach that includes clinical history, physical examination, laboratory tests, and imaging studies. The presence of a recent infection, characteristic symptoms, and the exclusion of other arthritic conditions are key components in confirming the diagnosis. If you have further questions or need more specific information, feel free to ask!

Reiter's disease, also known as reactive arthritis, is a type of inflammatory arthritis that can occur following an infection, particularly in the urogenital or gastrointestinal tract. The ICD-10 code M02.359 specifically refers to Reiter's disease affecting the unspecified hip. Treatment approaches for this condition typically focus on alleviating symptoms, managing inflammation, and addressing any underlying infections. Below is a detailed overview of standard treatment strategies.

Standard Treatment Approaches

1. Medications

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

NSAIDs are often the first line of treatment for managing pain and inflammation associated with Reiter's disease. Commonly used NSAIDs include ibuprofen and naproxen. These medications help reduce swelling and discomfort in the affected joints, including the hip[1].

Corticosteroids

In cases where NSAIDs are insufficient, corticosteroids may be prescribed. These can be administered orally or injected directly into the affected joint to provide rapid relief from inflammation and pain[2].

Disease-Modifying Antirheumatic Drugs (DMARDs)

For chronic cases or when the disease does not respond to NSAIDs or corticosteroids, DMARDs such as methotrexate may be considered. These medications help slow disease progression and prevent joint damage[3].

2. Physical Therapy

Physical therapy plays a crucial role in the rehabilitation of patients with Reiter's disease. A physical therapist can design a tailored exercise program to improve joint function, increase strength, and enhance mobility. Stretching and strengthening exercises can help maintain joint flexibility and reduce stiffness in the hip[4].

3. Management of Underlying Infections

Since Reiter's disease is often triggered by infections, it is essential to identify and treat any underlying infections. Antibiotics may be necessary if a bacterial infection is present, particularly if it is linked to the onset of arthritis symptoms[5].

4. Lifestyle Modifications

Patients are encouraged to adopt lifestyle changes that can help manage symptoms and improve overall health. This includes:

• Regular Exercise: Engaging in low-impact activities such as swimming or cycling can help maintain joint function without putting excessive strain on the hips.
• Weight Management: Maintaining a healthy weight can reduce stress on the hip joints, alleviating pain and improving mobility[6].
• Dietary Adjustments: A balanced diet rich in anti-inflammatory foods, such as omega-3 fatty acids, can support overall joint health[7].

5. Alternative Therapies

Some patients may find relief through alternative therapies, such as acupuncture or massage therapy. While these approaches may not be universally effective, they can complement traditional treatments and improve quality of life for some individuals[8].

Conclusion

The management of Reiter's disease, particularly when affecting the hip, involves a multifaceted approach that includes medication, physical therapy, and lifestyle modifications. Early intervention and a tailored treatment plan can significantly improve outcomes and enhance the quality of life for patients. It is essential for individuals experiencing symptoms to consult with a healthcare provider for a comprehensive evaluation and personalized treatment strategy.

For ongoing management, regular follow-ups with healthcare professionals are recommended to monitor the condition and adjust treatment as necessary.